Suchergebnisse - "Pirola, Carlos J"

PubPharm (231)

41

Genetics of Nonalcoholic Fatty Liver Disease : From Pathogenesis to Therapeutics

enthalten in: Seminars in liver disease | 2019

von Sookoian, S. | Pirola, C.

42

Repurposing drugs to target nonalcoholic steatohepatitis

enthalten in: World journal of gastroenterology | 2019

von Sookoian, S. | Pirola, C.

43

Review article : shared disease mechanisms between non-alcoholic fatty liver disease and metabolic syndrome - translating knowledge from systems biology to the bedside

enthalten in: Alimentary pharmacology & therapeutics | 2019

von Sookoian, S. | Pirola, C.

44

Genetics Meets Therapy? Exome-wide Association Study Reveals a Loss-of-Function Variant in 17-Beta-Hydroxysteroid Dehydrogenase 13 That Protects Patients From Liver Damage and Nonalcoholic Fatty Liver Disease Progression

enthalten in: Hepatology (Baltimore, Md.) | 2019

von Sookoian, S. | Arrese, M. | Pirola, C.

CommentOn: N Engl J Med. 2018 Mar 22;378(12):1096-1106. - PMID 29562163

45

Splice variant rs72613567 prevents worst histologic outcomes in patients with nonalcoholic fatty liver disease

enthalten in: Journal of lipid research | 2019

von Pirola, C. | Garaycoechea, M. | Flichman, D. | +5

46

Genetics Meets Therapy? Exome‐wide Association Study Reveals a Loss‐of‐Function Variant in 17‐Beta‐Hydroxysteroid Dehydrogenase 13 That Protects Patients From Liver Damage and Nonalcoholic Fatty Liver Disease Progression

enthalten in: Hepatology | 2019

von Sookoian, S. | Arrese, M. | Pirola, C.

47

Tackling the complexity of nonalcoholic steatohepatitis treatment : challenges and opportunities based on systems biology and machine learning approaches

enthalten in: Hepatobiliary surgery and nutrition | 2018

von Pirola, C. | Sookoian, S.

48

A Rare Nonsense Mutation in the Glucokinase Regulator Gene Is Associated With a Rapidly Progressive Clinical Form of Nonalcoholic Steatohepatitis

enthalten in: Hepatology communications | 2018

von Pirola, C. | Flichman, D. | Dopazo, H. | +7

49

Metastasis-associated lung adenocarcinoma transcript 1 as a common molecular driver in the pathogenesis of nonalcoholic steatohepatitis and chronic immune-mediated liver damage

enthalten in: Hepatology communications | 2018

von Sookoian, S. | Flichman, D. | Garaycoechea, M. | +3

50

Multiomics biomarkers for the prediction of nonalcoholic fatty liver disease severity

enthalten in: World journal of gastroenterology | 2018

von Pirola, C. | Sookoian, S.